Det vigtigste sikkerhedsproblem, der drøftedes, var den mulige øgede risiko for hypospadi efter anvendelse af loratadin under graviditet.
The main safety issue discussed was the possible increased risk of hypospadia following the use of loratadine during pregnancy.